USD800912S1 - Point-of-care diagnostic device - Google Patents

Point-of-care diagnostic device Download PDF

Info

Publication number
USD800912S1
USD800912S1 US29/568,417 US201629568417F USD800912S US D800912 S1 USD800912 S1 US D800912S1 US 201629568417 F US201629568417 F US 201629568417F US D800912 S USD800912 S US D800912S
Authority
US
United States
Prior art keywords
point
diagnostic device
care diagnostic
care
view
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US29/568,417
Inventor
Dina UZRI
Benedict L. Zin
Bradley Todd MESSMER
Inhoe KIM
Gad Shaanan
Jessie-Farah Fecteau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abreos Biosciences Inc
Original Assignee
Abreos Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abreos Biosciences Inc filed Critical Abreos Biosciences Inc
Priority to US29/568,417 priority Critical patent/USD800912S1/en
Assigned to ABREOS BIOSCIENCES, INC. reassignment ABREOS BIOSCIENCES, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MESSMER, BRADLEY T., SHAANAN, GAD, KIM, Inhoe, ZIN, BENEDICT L., FECTEAU, JESSIE-FARAH, UZRI, Dina
Application granted granted Critical
Publication of USD800912S1 publication Critical patent/USD800912S1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Description

FIG. 1 is a top perspective view of the point-of-care diagnostic device, as seen from the top, front, and side;
FIG. 2 is a top plan view thereof;
FIG. 3 is a front elevation view thereof;
FIG. 4 is a right side elevation view thereof;
FIG. 5 is a left side elevation view thereof;
FIG. 6 is a rear elevation view thereof;
FIG. 7 is a bottom plan view thereof; and,
FIG. 8 is a top perspective view of alternative embodiment of the point-of-care diagnostic device, showing the door slid in the open position.
The broken line depiction of a point-of-care device is included for the purpose of illustrating environmental structure and forms no part of the claimed design.

Claims (1)

    CLAIM
  1. The ornamental design for a point-of-care diagnostic device, as shown and described.
US29/568,417 2016-06-17 2016-06-17 Point-of-care diagnostic device Active USD800912S1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US29/568,417 USD800912S1 (en) 2016-06-17 2016-06-17 Point-of-care diagnostic device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29/568,417 USD800912S1 (en) 2016-06-17 2016-06-17 Point-of-care diagnostic device

Publications (1)

Publication Number Publication Date
USD800912S1 true USD800912S1 (en) 2017-10-24

Family

ID=60082941

Family Applications (1)

Application Number Title Priority Date Filing Date
US29/568,417 Active USD800912S1 (en) 2016-06-17 2016-06-17 Point-of-care diagnostic device

Country Status (1)

Country Link
US (1) USD800912S1 (en)

Cited By (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD839443S1 (en) 2017-04-20 2019-01-29 Biomerieux, Inc. Fluid testing base station
USD840040S1 (en) * 2017-09-07 2019-02-05 Riccardo Tonini Dental instrument
USD843013S1 (en) * 2017-01-25 2019-03-12 Hamamatsu Photonics K.K. Substrates for spectroscopic analysis
USD843011S1 (en) * 2017-01-25 2019-03-12 Hamamatsu Photonics K.K. Substrate for spectroscopic analysis
USD843010S1 (en) * 2017-01-25 2019-03-12 Hamamatsu Photonics K.K. Substrate for spectroscopic analysis
USD843012S1 (en) * 2017-01-25 2019-03-12 Hamamatsu Photonics K.K. Substrate for spectroscopic analysis
USD843594S1 (en) * 2017-01-25 2019-03-19 Hamamatsu Photonics K.K. Substrate for spectroscopic analysis
USD846145S1 (en) * 2018-01-08 2019-04-16 Fundamental Solutions Corporation Test cartridge base
USD851778S1 (en) 2017-04-20 2019-06-18 Biomerieux, Inc. Fluid testing base station
USD854184S1 (en) * 2017-01-25 2019-07-16 Hamamatsu Photonics K.K. Substrate for spectroscopic analysis
USD855205S1 (en) * 2017-01-25 2019-07-30 Hamamatsu Photonics K.K. Substrate for spectroscopic analysis
USD855210S1 (en) * 2017-01-25 2019-07-30 Hamamatsu Photonics K.K. Substrate for spectroscopic analysis
USD855208S1 (en) * 2017-01-25 2019-07-30 Hamamatsu Photonics K.K. Substrate for spectroscopic analysis
USD855209S1 (en) * 2017-01-25 2019-07-30 Hamamatsu Photonics K.K. Substrate for spectroscopic analysis
USD855206S1 (en) * 2017-01-25 2019-07-30 Hamamatsu Photonics K.K. Substrate for spectroscopic analysis
USD855207S1 (en) * 2017-01-25 2019-07-30 Hamamatsu Photonics K.K. Substrate for spectroscopic analysis
USD861913S1 (en) 2017-04-20 2019-10-01 Biomerieux, Inc. Fluid testing device
USD865996S1 (en) 2016-11-25 2019-11-05 Hologic, Inc. User interface for medical workstation
USD865998S1 (en) * 2016-11-25 2019-11-05 Hologic, Inc. User interface for medical workstation
USD865997S1 (en) 2016-11-25 2019-11-05 Hologic, Inc. User interface for medical workstation
USD866796S1 (en) * 2016-11-25 2019-11-12 Hologic, Inc. User interface for medical workstation
USD872283S1 (en) * 2016-03-23 2020-01-07 Easydx, Inc. Point of care device
USD874677S1 (en) * 2017-04-20 2020-02-04 Biomerieux, Inc. Testing apparatus set
USD876662S1 (en) * 2017-10-27 2020-02-25 Royal Biotech Inc Vial lab multi-reader
US10724079B2 (en) 2014-04-24 2020-07-28 Lucira Health, Inc. Colorimetric detection of nucleic acid amplification
USD895146S1 (en) * 2019-11-25 2020-09-01 Illumina, Inc. Reagent cartridge
USD906526S1 (en) * 2018-12-20 2020-12-29 Alveo Technologies, Inc. Diagnostic reader device
USD907232S1 (en) * 2018-12-21 2021-01-05 Lucira Health, Inc. Medical testing device
USD910200S1 (en) 2018-12-21 2021-02-09 Lucira Health, Inc. Test tube
USD913518S1 (en) * 2019-11-25 2021-03-16 Illumina, Inc. Reagent cartridge
US11080848B2 (en) 2017-04-06 2021-08-03 Lucira Health, Inc. Image-based disease diagnostics using a mobile device
US11125661B2 (en) 2016-03-14 2021-09-21 Lucira Health. Inc. Devices and methods for biological assay sample preparation and delivery
US11123736B2 (en) 2016-03-14 2021-09-21 Lucira Health, Inc. Systems and methods for performing biological assays
USD932618S1 (en) * 2016-04-01 2021-10-05 Huntleigh Technology Limited Diagnostic device
USD942033S1 (en) 2019-11-25 2022-01-25 Illumina, Inc. Reagent cartridge
US11291995B2 (en) 2016-03-14 2022-04-05 Lucira Health, Inc. Selectively vented biological assay devices and associated methods
USD949432S1 (en) 2019-11-25 2022-04-19 Illumina, Inc. Reagent cartridge
US11331662B2 (en) 2017-09-29 2022-05-17 Miraplex Diagnostics Inc. Assay preparation device
USD952892S1 (en) 2019-11-25 2022-05-24 Illumina, Inc. Sequencing cartridge assembly
USD953573S1 (en) 2019-11-25 2022-05-31 Illumina, Inc. Flow cell cartridge
USD953561S1 (en) 2020-05-05 2022-05-31 Lucira Health, Inc. Diagnostic device with LED display
USD953574S1 (en) 2019-11-25 2022-05-31 Illumina, Inc. Flow cell cartridge
USD962470S1 (en) 2020-06-03 2022-08-30 Lucira Health, Inc. Assay device with LCD display
USD962467S1 (en) 2019-11-25 2022-08-30 Illumina, Inc. Flow cell device
US11465142B2 (en) 2017-09-14 2022-10-11 Lucira Health, Inc. Multiplexed biological assay device with electronic readout
US11680948B2 (en) 2016-08-12 2023-06-20 Abreos Biosciences, Inc. Detection and quantification of natalizumab
USD999425S1 (en) 2019-11-25 2023-09-19 Illumina, Inc. Cartridge cover
US11954851B2 (en) 2021-06-30 2024-04-09 Pfizer Inc. Image-based disease diagnostics using a mobile device

Citations (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5281395A (en) 1990-12-27 1994-01-25 Boehringer Manheim Gmbh Test carrier analysis system
US5413764A (en) 1989-04-08 1995-05-09 Boehringer Mannheim Gmbh Test carrier analysis system
US5567594A (en) 1991-04-26 1996-10-22 Enteron, L.P. Methods and compositions for the detection and treatment of diseases associated with antigens of microorganisms
US5885577A (en) 1994-09-21 1999-03-23 Cytogen Corporation Antigen binding peptides (abtides) from peptide libraries
US6146589A (en) 1995-02-03 2000-11-14 British Biocell International Limited Assay device for detecting the presence of an analyte involving sequential delivery of reagents through a liquid circuit
US6210901B1 (en) 1994-01-31 2001-04-03 Roche Diagnostics Gmbh Specific binding substances for antibodies and their use for immunoassays or vaccines
US20030068664A1 (en) 2001-09-20 2003-04-10 Board Of Regents, The University Of Texas System Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
US20050084491A1 (en) 2003-06-23 2005-04-21 David Shealy Peptides antagonistic to an anti-angiogenic antibody and uses therefor
US20050191620A1 (en) 2004-02-27 2005-09-01 Mcdevitt John T. Particle on membrane assay system
US20050208587A1 (en) 2002-09-09 2005-09-22 Rosa Cardoso Peptides that bind to broadly neutralizing anti-HIV antibody-structure of 4E10 Fab fragment complex. uses thereof, compositions therefrom
US20050272106A1 (en) 2004-02-17 2005-12-08 Norman Moore Methods and kits for detection of multiple pathogens
US20060008920A1 (en) 2004-07-09 2006-01-12 Branan Medical Corporation Combination assay for alcohol and drugs of abuse
US20060068501A1 (en) 2004-09-30 2006-03-30 Nj International Llc Apparatus and methods for steroid hormone testing
US7074888B1 (en) 1995-03-17 2006-07-11 The Research Foundation Of State University Of New York Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/IX
US20060286379A1 (en) 2002-08-13 2006-12-21 Yong Gao Magnetic nanoparticle supports
WO2007022557A1 (en) 2005-08-23 2007-03-01 Diatech Pty Ltd Mimotopes of epstein-barr virus (ebv) epitopes
WO2009121024A2 (en) 2008-03-27 2009-10-01 The Regents Of The University Of California Methods for detecting antibodies
US20100330585A1 (en) 2007-06-27 2010-12-30 Inbios International, Inc. Lateral flow assay system and methods for its use
US20110117636A1 (en) 2009-11-18 2011-05-19 Infopia Co., Ltd. Lateral flow immunoassay device with a more rapid and accurate test result
US20110136155A1 (en) 2009-11-17 2011-06-09 Abaxis, Inc. Peptides and methods for the detection of lyme disease antibodies
US20110320130A1 (en) 2010-06-25 2011-12-29 Dexcom, Inc. Systems and methods for communicating sensor data between communication devices
WO2012023053A2 (en) 2010-08-16 2012-02-23 Novimmune S.A. Methods for the generation of multispecific and multivalent antibodies
US8193002B2 (en) 2003-02-13 2012-06-05 Alere Switzerland Gmbh Lateral flow immunoassay controls
US20120220049A1 (en) 2009-03-31 2012-08-30 Biofortuna Ltd Assay method and device
US20120225423A1 (en) 2001-02-07 2012-09-06 Massachusetts Institute Of Technology Pathogen detection biosensor
US20130040401A1 (en) 2011-08-12 2013-02-14 Benedict L. Zin Test strip reader
US20130085349A1 (en) 2011-06-21 2013-04-04 Yofimeter, Llc Analyte testing devices
US20130130404A1 (en) 2011-11-21 2013-05-23 Abaxis, Inc Signal amplification in lateral flow and related immunoassays
US20130143246A1 (en) 2011-12-02 2013-06-06 Lifescan Scotland Ltd. Hand-held test meter with analytical test strip ejection mechanism
US8507216B2 (en) 2007-11-12 2013-08-13 Hiroshima University Kit for measurement of endotoxin level by bioluminescent assay
US20150293086A1 (en) 2014-04-14 2015-10-15 Abreos Biosciences, Inc. Lateral flow immunoassay
US20150301031A1 (en) 2014-04-17 2015-10-22 Church & Dwight Co., Inc. Electronic test device data communication
WO2016123105A1 (en) 2015-01-26 2016-08-04 Abreos Biosciences, Inc. Cleavage coupled competitive lateral flow assay
USD774205S1 (en) * 2015-12-24 2016-12-13 Beckman Coulter, Inc. Diagnostic device

Patent Citations (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5413764A (en) 1989-04-08 1995-05-09 Boehringer Mannheim Gmbh Test carrier analysis system
US5281395A (en) 1990-12-27 1994-01-25 Boehringer Manheim Gmbh Test carrier analysis system
US5567594A (en) 1991-04-26 1996-10-22 Enteron, L.P. Methods and compositions for the detection and treatment of diseases associated with antigens of microorganisms
US6210901B1 (en) 1994-01-31 2001-04-03 Roche Diagnostics Gmbh Specific binding substances for antibodies and their use for immunoassays or vaccines
US5885577A (en) 1994-09-21 1999-03-23 Cytogen Corporation Antigen binding peptides (abtides) from peptide libraries
US6146589A (en) 1995-02-03 2000-11-14 British Biocell International Limited Assay device for detecting the presence of an analyte involving sequential delivery of reagents through a liquid circuit
US7074888B1 (en) 1995-03-17 2006-07-11 The Research Foundation Of State University Of New York Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/IX
US20120225423A1 (en) 2001-02-07 2012-09-06 Massachusetts Institute Of Technology Pathogen detection biosensor
US20030068664A1 (en) 2001-09-20 2003-04-10 Board Of Regents, The University Of Texas System Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
US20060286379A1 (en) 2002-08-13 2006-12-21 Yong Gao Magnetic nanoparticle supports
US20050208587A1 (en) 2002-09-09 2005-09-22 Rosa Cardoso Peptides that bind to broadly neutralizing anti-HIV antibody-structure of 4E10 Fab fragment complex. uses thereof, compositions therefrom
US8193002B2 (en) 2003-02-13 2012-06-05 Alere Switzerland Gmbh Lateral flow immunoassay controls
US20050084491A1 (en) 2003-06-23 2005-04-21 David Shealy Peptides antagonistic to an anti-angiogenic antibody and uses therefor
US20050272106A1 (en) 2004-02-17 2005-12-08 Norman Moore Methods and kits for detection of multiple pathogens
US20050191620A1 (en) 2004-02-27 2005-09-01 Mcdevitt John T. Particle on membrane assay system
US20060008920A1 (en) 2004-07-09 2006-01-12 Branan Medical Corporation Combination assay for alcohol and drugs of abuse
US20060068501A1 (en) 2004-09-30 2006-03-30 Nj International Llc Apparatus and methods for steroid hormone testing
WO2007022557A1 (en) 2005-08-23 2007-03-01 Diatech Pty Ltd Mimotopes of epstein-barr virus (ebv) epitopes
US20100330585A1 (en) 2007-06-27 2010-12-30 Inbios International, Inc. Lateral flow assay system and methods for its use
US8507216B2 (en) 2007-11-12 2013-08-13 Hiroshima University Kit for measurement of endotoxin level by bioluminescent assay
US20160146829A1 (en) 2008-03-27 2016-05-26 The Regents Of The University Of California Methods for detecting antibodies
US9250233B2 (en) 2008-03-27 2016-02-02 The Regents Of The University Of California Methods for detecting antibodies
WO2009121024A2 (en) 2008-03-27 2009-10-01 The Regents Of The University Of California Methods for detecting antibodies
US20120220049A1 (en) 2009-03-31 2012-08-30 Biofortuna Ltd Assay method and device
US20110136155A1 (en) 2009-11-17 2011-06-09 Abaxis, Inc. Peptides and methods for the detection of lyme disease antibodies
US20110117636A1 (en) 2009-11-18 2011-05-19 Infopia Co., Ltd. Lateral flow immunoassay device with a more rapid and accurate test result
US20110320130A1 (en) 2010-06-25 2011-12-29 Dexcom, Inc. Systems and methods for communicating sensor data between communication devices
WO2012023053A2 (en) 2010-08-16 2012-02-23 Novimmune S.A. Methods for the generation of multispecific and multivalent antibodies
US20130085349A1 (en) 2011-06-21 2013-04-04 Yofimeter, Llc Analyte testing devices
US20130040401A1 (en) 2011-08-12 2013-02-14 Benedict L. Zin Test strip reader
US20130130404A1 (en) 2011-11-21 2013-05-23 Abaxis, Inc Signal amplification in lateral flow and related immunoassays
US20130143246A1 (en) 2011-12-02 2013-06-06 Lifescan Scotland Ltd. Hand-held test meter with analytical test strip ejection mechanism
US20150293086A1 (en) 2014-04-14 2015-10-15 Abreos Biosciences, Inc. Lateral flow immunoassay
WO2015160834A1 (en) 2014-04-14 2015-10-22 Abreos Biosciences, Inc. Lateral flow immunoassay
US20150301031A1 (en) 2014-04-17 2015-10-22 Church & Dwight Co., Inc. Electronic test device data communication
WO2016123105A1 (en) 2015-01-26 2016-08-04 Abreos Biosciences, Inc. Cleavage coupled competitive lateral flow assay
USD774205S1 (en) * 2015-12-24 2016-12-13 Beckman Coulter, Inc. Diagnostic device

Non-Patent Citations (69)

* Cited by examiner, † Cited by third party
Title
Adams et al. Monoclonal antibody therapy of cancer. Nat Biotechnol. 23:1147-1157 (2005).
Barenholz et al. A peptide mimetic of the mycobacterial mannosylated lipoarabinomannan: characterization and potential applications. J Med Microbiol 56(pt 5):579-586 (2007).
Barnett et al. In-Field Implementation of a Recombinant Factor C Assay for the Detection of Lipopolysaccharide as a Biomarker of Extant Life within Glacial Environments. Biosensors (Basel) 2(1):83-100 (2012).
Bazin et al. Rapid visual tests: fast and reliable detection of ochratoxin A. Toxins (Basel) 2(9):2230-2241 (2010).
Beum et al. Three new assays for rituximab based on its immunological activity or antigenic properties: analyses of sera and plasmas of RTX-treated patients with chronic lymphocytic leukemia and other B cell lymphomas. J Immunol Methods 289(1-2)97-109 (2004).
Blasco et al. Evaluation of a peptide ELISA for the detection of rituximab in serum. J Immun Methods 325(1-2):127-139 (2007).
Breidenbach et al. Substrate recognition strategy for botulinum neurotoxin serotype A. Nature 432(7019):925-929 (2004).
Brissette et al. Identification of cancer targets and therapeutics using phage display. Curr Opin Drug Discov Devel 9:363-369 (2006).
Carpino et al. 9-Fluorenylmethoxycarbonyl amino-protecting group. J Org Chem 37(22)3404-3409 (1972).
Colman et al. Effects of amino acid sequence changes on antibody-antigen interactions. Research in Immunology 145(1):33-36 (1994).
Co-pending U.S. Appl. No. 15/185,549, filed Jun. 17, 2016.
Co-pending U.S. Appl. No. 29/568,418, filed Jun. 17, 2016.
Dalakas et al. Effect of Alemtuzumab (Campath 1H) in patients with inclusion-body myositis. Brain 132:1536-1544 (2009).
Degardin et al. Understanding and fighting the medicine counterfeit market. J Pharm Biomed Anal 87:167-175 (2013).
Delano et al. Convergent solutions to binding at a protein-protein interface. Science 287(5456):1279-1283 (2000).
Ding et al. Endotoxin detection-from limulus amebocyte lysate to recombinant factor C. Subcell Biochem 53:187-208 (2010).
FDA-definition of biological product. http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/ucm113522.htm (Jul. 2015).
Feltrup et al. Development of a fluorescence internal quenching correction factor to correct botulinum neurotoxin type a endopeptidase kinetics using SNAPtide. Anal Chem 84(24):10549-10553 (2012).
Fernandez-Salas et al. Botulinum Neurotoxin Serotype a Specific Cell-Based Potency Assay to Replace the Mouse Bioassay. PLoS One 7(11):e49516 (2012).
Golden et al. Extended result reading window in lateral flow tests detecting exposure to Onchocerca volvulus: a new technology to improve epidemiological surveillance tools. PLoS One 8(7):e69231 (2013).
Hale et al. Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration. Blood 104(4):948-955 (2004).
Hale. Synthetic peptide mimotope of the CAMPATH-1 (CD52) antigen, a small glycosylphosphatidylinositol-anchored glycoprotein. Immunotechnology 1(3-4):175-187 (1995).
Harlow et al. Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 23-26 (1988).
Jiang et al. A novel peptide isolated from a phage display peptide library with trastuzumab can mimic antigen epitope of HER-2 J Biol Chem 280(6):4656-4662 (2004).
Jilani et al. Alemtuzumab: validation of a sensitive and simple enzyme-linked immunosorbent assay. Leuk Res 28(12):1255-1262 (2004).
Joiner et al. Comparison of Endotoxin Testing Methods for Pharmaceutical Products. Int J Pharm Compd 6:408-409 (2002).
Jones et al. Development of improved SNAP25 endopeptidase immuno-assays for botulinum type A and E toxins. J Immunol Meth 329(1-2):92-101 (2008).
Kosik et al. Studies of enzymatic cleavage of cellulose using polysaccharide analysis by carbohydrate gel electrophoresis (PACE). Methods Enzymol 510:51-67 (2012).
Laderman et al. Rapid, sensitive, and specific lateral-flow immunochromatographic point-of-care device for detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in serum and whole blood. Clin Vaccine Immunol. 15(1):159-163 (2007).
Lederman et al. A single amino acid substitution in a common African allele of the CD4 molecule ablates binding of the monoclonal antibody, OKT4. Mol Immunol 28(11):1171-1181 (1991).
Lee et al. Performance improvement of the one-dot lateral flow immunoassay for aflatoxin B1 by using a smartphone-based reading system. Sensors (Basel) 13(4):5109-5116 (2013).
Lonza Limulus Amebocyte Lysate (LAL) QCL-1000. Available from: http://bio.lonza.com/uploads/txmwaxmarketingmaterial/Lonza ManualsProductInstructions CL-1000 Product Insert.pdf (2007).
Maloney et al. IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood 90(6):2188-2195 (1997).
Manshouri et al. Circulating CD20 is detectable in the plasma of patients with chronic lymphocytic leukemia and is of prognostic significance. Blood 101(7):2507-2513 (2002).
McDade et al. What a Drop Can Do: Dried Blood Spots As a Minimally Invasive Method for Integrating Biomarkers into Population Based Research. Demography 44(4):899-925 (2007).
Merrifield. Solid Phase Peptide Synthesis I. J Am Chem Soc 85:2149-2154 (1963).
Messmer et al. Specific blocking to improve biopanning in biological samples such as serum and hybridoma supernatants. Biotechniques 30(4):798-802 (2001).
Messmer et al. Two human neonatal IgM antibodies encoded by different variable-region genes bind the same linear peptide: evidence for a stereotyped repertoire of epitope recognition. J Immun 162(4):2184-2192 (1999).
Montagna et al. A new sensitive enzyme-linked immunosorbent assay (ELISA) for Alemtuzumab determination: development, validation and application. Int J Immunopathol Pharmacol 20(2):363-371 (2007).
Mulvaney et al. Incorporating fluorescent dyes and quantum dots into magnetic microbeads for immunoassays. Biotechniques. 36(4):602-609 (2004).
Nakamura et al. Lipopolysaccharide-sensitive serine-protease zymogen (factor C) found in Limulus hemocytes. Isolation and characterization. Eur J Biochem 154:511-521 (1986).
Nakano et al. ELISAs for free human immunoglobulin light chains in serum: improvement of assay specificity by using two specific antibodies in a sandwich detection method. J Immunol Methods 293:183-189 (2004).
Ouimet et al. Comparison of Fluorigenic Peptide Substrates PL50, SNAPtide, and BoTest A/E for BoNT/A Detection and Quantification: Exosite Binding Confers High-Assay Sensitivity. Journal of Biomolecular Screening 18(6):726-735 (2013).
PCT/US2009/038674 International Preliminary Report on Patentability dated Sep. 28, 2010.
PCT/US2009/038674 International Search Report and Written Opinion dated Dec. 24, 2009.
PCT/US2015/025796 International Preliminary Report on Patentability dated Oct. 27, 2016.
PCT/US2015/025796 International Search Report and Written Opinion dated Aug. 21, 2015.
PCT/US2016/14924 International Search Report and Written Opinion dated Apr. 8, 2016.
Perosa et al. Identification of an antigenic and immunogenic motif expressed by two 7-merrituximab-specific cyclic peptide mimotopes: implication for peptide-based active immunotherapy. J Immunol 179(11):7967-7974 (2007).
Pierce® LAL Chromogenic Endotoxin Quantitation Kit. Available from: https://www.piercenet.com/instructions/2162445.pdf (2013).
Poras et al. Detection and Quantification of Botulinum Neurotoxin Type A by a Novel Rapid In Vitro Fluorimetric Assay. Applied and Environmental Microbiology 75(13):4382-4390 (2009).
Rebello et al. Pharmacokinetics of CAMPATH-1H: assay development and validation. J Immunol Methods 260(1-2):285-302 (2002).
Rohr et al. Immunoassay employing surface-enhanced Raman spectroscopy. Anal Biochem 182(2):388-398 (1989).
Sanchez et al. A general process for the development of peptide-based immunoassays for monoclonal antibodies. Cancer Chemother Pharmacol 66(5):919-925 (2010).
Shin et al. Combinatorial solid phase peptide synthesis and bioassays. J Biochem Mol Biol 38(5):517-525 (2005).
Sosnick et al. Distances between the antigen-binding sites of three murine antibody subclasses measured using neutron and X-ray scattering. Biochemistry 31:1779-1786 (1992).
Tan et al. Pharmacokinetics of Cetuximab After Administration of Escalating Single Dosing and Weekly Fixed Dosing in Patients with Solid Tumors. Clin Cancer Res. 12(21):6517-6522 (2006).
Tian et al. Antigen peptide-based immunosensors for rapid detection of antibodies and antigens. Anal Chem 81(13):5218-5225 (2009).
Titov et al. Development and optimization of immunoassays for the detection of botulinum toxins. Prikl Biokhim Mikrobiol 48(2):249-256 (2012).
Tokunaga et al. Further studies on lipopolysaccharide-sensitive serine protease zymogen (factor C): its isolation from Limulus polyphemus hemocytes and identification as an intracellular zymogen activated by alpha-chymotrypsin, not by trypsin. J Biochem 109:150-157 (1991).
U.S. Appl. No. 14/686,578 Office Action dated Oct. 14, 2016.
U.S. Appl. No. 14/981,715 Office Action dated Jul. 12, 2016.
U.S. Serial No. 12/934,624 Office Action dated Aug. 22, 2014.
U.S. Serial No. 12/934,624 Office Action dated Jan. 8, 2014.
U.S. Serial No. 12/934,624 Office Action dated Mar. 27, 2015.
U.S. Serial No. 14/981,715 Office Action dated Jan. 19, 2017.
U.S. Serial No. 15/185,549 Office Action dated Jan. 6, 2017.
Wang et al. Acute intraocular inflammation caused by endotoxin after intravitreal injection of counterfeit bevacizumab in Shanghai, China. Ophthalmology 120(2):355-361 (2013).
Williams et al. Thrice-weekly low-dose rituximab decreases CD20 loss via shaving and promotes enhanced targeting in chronic lymphocytic leukemia. J Immunol 177:7435-7443 (2006).

Cited By (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10724079B2 (en) 2014-04-24 2020-07-28 Lucira Health, Inc. Colorimetric detection of nucleic acid amplification
US11584957B2 (en) 2014-04-24 2023-02-21 Lucira Health, Inc. Colorimetric detection of nucleic acid amplification
US11125661B2 (en) 2016-03-14 2021-09-21 Lucira Health. Inc. Devices and methods for biological assay sample preparation and delivery
US11123736B2 (en) 2016-03-14 2021-09-21 Lucira Health, Inc. Systems and methods for performing biological assays
US11291995B2 (en) 2016-03-14 2022-04-05 Lucira Health, Inc. Selectively vented biological assay devices and associated methods
USD872283S1 (en) * 2016-03-23 2020-01-07 Easydx, Inc. Point of care device
USD932618S1 (en) * 2016-04-01 2021-10-05 Huntleigh Technology Limited Diagnostic device
US11680948B2 (en) 2016-08-12 2023-06-20 Abreos Biosciences, Inc. Detection and quantification of natalizumab
USD866796S1 (en) * 2016-11-25 2019-11-12 Hologic, Inc. User interface for medical workstation
USD865997S1 (en) 2016-11-25 2019-11-05 Hologic, Inc. User interface for medical workstation
USD865998S1 (en) * 2016-11-25 2019-11-05 Hologic, Inc. User interface for medical workstation
USD865996S1 (en) 2016-11-25 2019-11-05 Hologic, Inc. User interface for medical workstation
USD843594S1 (en) * 2017-01-25 2019-03-19 Hamamatsu Photonics K.K. Substrate for spectroscopic analysis
USD855209S1 (en) * 2017-01-25 2019-07-30 Hamamatsu Photonics K.K. Substrate for spectroscopic analysis
USD855206S1 (en) * 2017-01-25 2019-07-30 Hamamatsu Photonics K.K. Substrate for spectroscopic analysis
USD855207S1 (en) * 2017-01-25 2019-07-30 Hamamatsu Photonics K.K. Substrate for spectroscopic analysis
USD855208S1 (en) * 2017-01-25 2019-07-30 Hamamatsu Photonics K.K. Substrate for spectroscopic analysis
USD855210S1 (en) * 2017-01-25 2019-07-30 Hamamatsu Photonics K.K. Substrate for spectroscopic analysis
USD855205S1 (en) * 2017-01-25 2019-07-30 Hamamatsu Photonics K.K. Substrate for spectroscopic analysis
USD854184S1 (en) * 2017-01-25 2019-07-16 Hamamatsu Photonics K.K. Substrate for spectroscopic analysis
USD843012S1 (en) * 2017-01-25 2019-03-12 Hamamatsu Photonics K.K. Substrate for spectroscopic analysis
USD843010S1 (en) * 2017-01-25 2019-03-12 Hamamatsu Photonics K.K. Substrate for spectroscopic analysis
USD843011S1 (en) * 2017-01-25 2019-03-12 Hamamatsu Photonics K.K. Substrate for spectroscopic analysis
USD843013S1 (en) * 2017-01-25 2019-03-12 Hamamatsu Photonics K.K. Substrates for spectroscopic analysis
US11080848B2 (en) 2017-04-06 2021-08-03 Lucira Health, Inc. Image-based disease diagnostics using a mobile device
USD851778S1 (en) 2017-04-20 2019-06-18 Biomerieux, Inc. Fluid testing base station
USD839443S1 (en) 2017-04-20 2019-01-29 Biomerieux, Inc. Fluid testing base station
USD874677S1 (en) * 2017-04-20 2020-02-04 Biomerieux, Inc. Testing apparatus set
USD861913S1 (en) 2017-04-20 2019-10-01 Biomerieux, Inc. Fluid testing device
USD840040S1 (en) * 2017-09-07 2019-02-05 Riccardo Tonini Dental instrument
US11465142B2 (en) 2017-09-14 2022-10-11 Lucira Health, Inc. Multiplexed biological assay device with electronic readout
US11331662B2 (en) 2017-09-29 2022-05-17 Miraplex Diagnostics Inc. Assay preparation device
USD876662S1 (en) * 2017-10-27 2020-02-25 Royal Biotech Inc Vial lab multi-reader
USD846145S1 (en) * 2018-01-08 2019-04-16 Fundamental Solutions Corporation Test cartridge base
USD906526S1 (en) * 2018-12-20 2020-12-29 Alveo Technologies, Inc. Diagnostic reader device
USD907232S1 (en) * 2018-12-21 2021-01-05 Lucira Health, Inc. Medical testing device
USD955598S1 (en) 2018-12-21 2022-06-21 Lucira Health, Inc. Medical testing device
USD910200S1 (en) 2018-12-21 2021-02-09 Lucira Health, Inc. Test tube
USD895146S1 (en) * 2019-11-25 2020-09-01 Illumina, Inc. Reagent cartridge
USD962467S1 (en) 2019-11-25 2022-08-30 Illumina, Inc. Flow cell device
USD953573S1 (en) 2019-11-25 2022-05-31 Illumina, Inc. Flow cell cartridge
USD1012313S1 (en) 2019-11-25 2024-01-23 Illumina, Inc. Flow cell cartridge
USD953574S1 (en) 2019-11-25 2022-05-31 Illumina, Inc. Flow cell cartridge
USD942033S1 (en) 2019-11-25 2022-01-25 Illumina, Inc. Reagent cartridge
USD1003452S1 (en) 2019-11-25 2023-10-31 Illumina, Inc. Flow cell device
USD952892S1 (en) 2019-11-25 2022-05-24 Illumina, Inc. Sequencing cartridge assembly
USD913518S1 (en) * 2019-11-25 2021-03-16 Illumina, Inc. Reagent cartridge
USD949432S1 (en) 2019-11-25 2022-04-19 Illumina, Inc. Reagent cartridge
USD942034S1 (en) 2019-11-25 2022-01-25 Illumina, Inc. Reagent cartridge
USD999425S1 (en) 2019-11-25 2023-09-19 Illumina, Inc. Cartridge cover
USD953561S1 (en) 2020-05-05 2022-05-31 Lucira Health, Inc. Diagnostic device with LED display
USD962470S1 (en) 2020-06-03 2022-08-30 Lucira Health, Inc. Assay device with LCD display
US11954851B2 (en) 2021-06-30 2024-04-09 Pfizer Inc. Image-based disease diagnostics using a mobile device

Similar Documents

Publication Publication Date Title
USD800912S1 (en) Point-of-care diagnostic device
USD850451S1 (en) Case for electronic device
USD823762S1 (en) Vehicle decklid
USD803825S1 (en) Electronic device
USD806388S1 (en) Case
USD806080S1 (en) Case for electronic device
USD817509S1 (en) Diagnostic device
USD860893S1 (en) Vehicle side panel
USD875737S1 (en) Hinge for a computing device
USD790550S1 (en) Case for electronic device
USD776645S1 (en) Case for an electronic device
USD768635S1 (en) Device attachment
USD772772S1 (en) Vehicle door
USD778707S1 (en) Closing device
USD774995S1 (en) Automobile grille and/or replica thereof
USD798139S1 (en) Clamp
USD958135S1 (en) Electronic device
USD726701S1 (en) Exoskeleton combo case
USD774505S1 (en) Electronic device
USD870717S1 (en) Case for protecting a mobile device
USD727331S1 (en) Electronic device cover
USD784219S1 (en) Engine cover
USD762302S1 (en) Surgical forceps
USD791575S1 (en) Door reinforcement device
USD809968S1 (en) Front cowl for a vehicle